对于高伤性阻塞性心肌病的中枢干预措施
Mony Shuvy1, Yael Yan Postell1, Shemy Carasso1
1Jesselson Integrated Heart Centre, Shaare Zedek Medical Center and Faculty of Medicine, Hebrew University, Jerusalem, Israel.
The Canadian journal of cardiology
|December 18, 2023
概括
超大致阻塞性心肌病 (HOCM) 涉及到中枢 (MV). 过导管边缘到边缘修复 (TEER) 提供了一种有前途的新疗法,用于减少HOCM患者的额头上和左心室外流通道阻塞.
科学领域:
- 心脏病学 心脏病学
- 心脏外科手术 心脏外科手术
- 干预心脏病学 干预心脏病学
背景情况:
- 额头 (MV) 是高压阻塞性心肌病 (HOCM) 病理生理学的组成部分.
- 在大多数HOCM患者中,MV的缩前运动 (SAM) 会导致动态左心室外流通道 (LVOT) 阻塞.
- 在HOCM中, mitralia regurgitation (MR) 往往需要特定的MV干预.
研究的目的:
- 审查MV在HOCM病原发生中的作用.
- 讨论HOCM目前的医疗和外科治疗方法.
- 探索新的中枢干预措施,特别是跨导管边缘到边缘修复 (TEER.
主要方法:
- 对HOCM中MV疾病的现有文献的审查.
- 讨论手术肌切除术和酒精隔膜切除.
- 重点是TEER对HOCM的应用和结果.
主要成果:
- 对于持久的LVOT阻塞和MR缓解,通常需要使用MV修改的外科肌切除术.
- TEER是对HOCM的有效和安全的新兴选择.
- TEER减少SAM,可能缓解LVOT阻塞和MR.
结论:
- MV装置是HOCM管理中的一个关键目标.
- 对于HOCM患者来说,TEER是一个有前途的治疗途径,特别是那些其他手术风险较高的患者.
- 在HOCM中提出了TEER的治疗算法.
相关概念视频
01:26Heart Failure Drugs: Inhibitors of Renin-Angiotensin System
436
The activation of the sympathetic nervous system and the renin-angiotensin-aldosterone system (RAAS) contributes to cardiac remodeling, and inhibiting the RAAS is a pharmacological target in heart failure management. As a result, neurohumoral modulation is a crucial treatment principle for managing heart failure. This approach involves using medications like ACE inhibitors (ACEIs), angiotensin receptor blockers (ARBs), β-blockers, mineralocorticoid receptor antagonists (MRAs), and neutral...
436
01:22Heart Failure Drugs: β-Blockers
341
β-adrenergic antagonists, commonly known as β-blockers, block the effects of sympathetic neurotransmitters such as noradrenaline (NA) and adrenaline (ADR). They have several beneficial effects in heart failure treatment. They reduce heart rate, the force of contraction, and cardiac muscle relaxation. They also slow the atrial-ventricular conduction rate and raise the threshold for arrhythmias. The concentration of β-blockers determines their effects on bronchodilation,...
341